Preeclampsia (PE) is the leading cause of poor maternal and perinatal outcomes in both developed and developing countries. Even though the condition is treatable in the developed world, mothers from developing countries still suffer dramatic events due to limited resources. There is the need to identify readily available measures in addition to existing biomarkers that can predict PE. Thus, this thesis evaluated suboptimal health status (SHS) and prospective levels of oxidative stress (OS) biomarkers and angiogenic growth mediators (AGMs) with placental anatomy and pathology in normotensive and preeclamptic births in a Ghanaian Population. This longitudinal nested case-control study was based on the Ghanaian Suboptimal Health Status Cohort ...
Purpose: To investigate the predictive performance of placental growth factor (PlGF) and soluble FMS...
Angiogenic factors are strongly associated with adverse maternal and fetal outcomes among women with...
More than half of all cases of preeclampsia occur in healthy first-time pregnant women. Our aim was ...
Preeclampsia (PE) is the leading cause of poor maternal and perinatal outcomes in both developed and...
Background Angiogenic growth mediators (AGMs) and oxidative stress (OS) both play essential roles i...
Pregnant women, particularly in developing countries are facing a huge burden of preeclampsia (PE) l...
BACKGROUND:Advanced maternal age (AMA) has been associated with negative pregnancy outcomes. Oxidati...
Background Advanced maternal age (AMA) has been associated with negative pregnancy outcomes. Oxidati...
Optimal oxidative stress (OS) is important throughout pregnancy; however, an increased OS may alter ...
Background: Normotensive pregnancy may develop into preeclampsia (PE) and other adverse pregnancy co...
BACKGROUND: We assessed whether adding the biomarkers Pregnancy Associated Plasma Protein-A (PAPP-A)...
Hypertensive disorders of pregnancy are important causes of maternal morbidity and mortality. This t...
Objective: Our objective was to determine whether measurement of placenta growth factor (PLGF), inhi...
Objective: To determine if change in maternal angiogenic biomarkers between the first and second tri...
Objective: To identify clinical characteristics and biochemical markers in first-trimester samples t...
Purpose: To investigate the predictive performance of placental growth factor (PlGF) and soluble FMS...
Angiogenic factors are strongly associated with adverse maternal and fetal outcomes among women with...
More than half of all cases of preeclampsia occur in healthy first-time pregnant women. Our aim was ...
Preeclampsia (PE) is the leading cause of poor maternal and perinatal outcomes in both developed and...
Background Angiogenic growth mediators (AGMs) and oxidative stress (OS) both play essential roles i...
Pregnant women, particularly in developing countries are facing a huge burden of preeclampsia (PE) l...
BACKGROUND:Advanced maternal age (AMA) has been associated with negative pregnancy outcomes. Oxidati...
Background Advanced maternal age (AMA) has been associated with negative pregnancy outcomes. Oxidati...
Optimal oxidative stress (OS) is important throughout pregnancy; however, an increased OS may alter ...
Background: Normotensive pregnancy may develop into preeclampsia (PE) and other adverse pregnancy co...
BACKGROUND: We assessed whether adding the biomarkers Pregnancy Associated Plasma Protein-A (PAPP-A)...
Hypertensive disorders of pregnancy are important causes of maternal morbidity and mortality. This t...
Objective: Our objective was to determine whether measurement of placenta growth factor (PLGF), inhi...
Objective: To determine if change in maternal angiogenic biomarkers between the first and second tri...
Objective: To identify clinical characteristics and biochemical markers in first-trimester samples t...
Purpose: To investigate the predictive performance of placental growth factor (PlGF) and soluble FMS...
Angiogenic factors are strongly associated with adverse maternal and fetal outcomes among women with...
More than half of all cases of preeclampsia occur in healthy first-time pregnant women. Our aim was ...